Zembrace symtouch and Nausea aggravated - a phase IV clinical study of FDA data

Summary:

Nausea aggravated is reported as a side effect among people who take Zembrace symtouch (sumatriptan succinate), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Tylenol, and have Migraine.

The phase IV clinical study analyzes which people have Nausea aggravated when taking Zembrace symtouch. It is created by eHealthMe based on reports of 230 people who have side effects when taking Zembrace symtouch from the FDA, and is updated regularly.

What is Zembrace symtouch?

Zembrace symtouch has active ingredients of sumatriptan succinate. eHealthMe is studying from 232 Zembrace symtouch users. Check the latest studies of Zembrace symtouch.

What is Nausea aggravated?

Nausea aggravated (an urge to vomit) is found to be associated with 3,400 drugs and 1,083 conditions by eHealthMe. Check the latest studies of Nausea aggravated.

On Jul, 23, 2026

230 people reported to have side effects when taking Zembrace symtouch.
Among them, 11 people (4.78%) have Nausea aggravated.

Could Zembrace symtouch cause Nausea aggravated?

Among these 11 people:

How long have people been on Zembrace symtouch when they have Nausea aggravated? *

What is the gender of people who have Nausea aggravated when taking Zembrace symtouch? *

female: 100 %
male: 0.0 %

What is the age of people who have Nausea aggravated when taking Zembrace symtouch? *

What are other drugs people take besides Zembrace symtouch? *

What are other side effects people have besides Nausea aggravated? *

Headache (pain in head): 4 people, 36.36%
Heart Rate Decreased: 3 people, 27.27%
Migraine (headache): 3 people, 27.27%
Nausea And Vomiting: 3 people, 27.27%
Oedema (fluid collection in tissue): 2 people, 18.18%
Fall: 2 people, 18.18%
Itching: 2 people, 18.18%
Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 18.18%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 18.18%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 2 people, 18.18%

What are the existing conditions these people have? *

Migraine (headache): 5 people, 45.45%
Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 27.27%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 18.18%
Muscle Spasms (muscle contraction): 2 people, 18.18%
Herpes Zoster: 2 people, 18.18%
Headache (pain in head): 2 people, 18.18%
Sleep Disorder: 1 person, 9.09%
Progressive Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Zembrace symtouch and have Nausea aggravated?

- Check whether Nausea aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zembrace symtouch:

Zembrace symtouch (232 reports)

Browse all side effects of Zembrace symtouch:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nausea aggravated:

Nausea aggravated (3,400 drugs)

Browse all the conditions that are associated with Nausea aggravated:

Nausea aggravated (1,083 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate (the active ingredients of Zembrace symtouch) and Zembrace symtouch (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.